The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

The National Institute for Standards and Technology’s new harm reduction initiative is helping prevent needless deaths.

Additional Evidence of PF614-MPAR Overdose Protection after Completion of Part 1 of Clinical Study ~ SAN DIEGO, CA / / April 15, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" ...

A groundbreaking study conducted by neonatologists has revealed that babies exposed to opioids in the womb tend to have ...

The Trump administration’s plan to address the opioid crisis focuses on preventing overdose deaths, but neglects the ...

Welcome to the world of opioid prescribing, where government mandates based upon Morphine Milligram Equivalents (MMEs) are ...

The same chemicals and receptors that control the sensation of pain in the opioid system also play a role in regulating ...

South Rampart Pharma, Inc. ("South Rampart" or the "Company"), a clinical-stage biotechnology company advancing best-in-class ...

Pharmaceutical companies accused of fueling the nation’s opioid crisis are paying state and local governments billions of ...

VTRS has reached an agreement of $335 million to resolve opioid-related claims by states, local governments, and tribes against it and certain of its subsidiaries.

over 6000 assets (including all Forex pairs, Cryptocurrencies, Commodities, Indices and US stocks) unique interbank rates extensive historic data the option to save your configuration Here below ...

For decades the pain drug market has been dominated by opioids that cause adverse side ... the drug company pursuing acute pain with a first-in-class NaV1.8 pain signal inhibitor drug.